Home > Balance Sheet > BLISS GVS PHARMA

BLISS GVS PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
BLISS GVS PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹37 Cr₹51 Cr₹43 Cr₹29 Cr₹45 Cr

What is the latest Total Non-Current Liabilities ratio of BLISS GVS PHARMA ?

The latest Total Non-Current Liabilities ratio of BLISS GVS PHARMA is ₹37 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹37 Cr
Mar2024₹51 Cr
Mar2023₹43 Cr
Mar2022₹29 Cr
Mar2021₹45 Cr

How is Total Non-Current Liabilities of BLISS GVS PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹37 Cr
-27.20
Mar2024 ₹51 Cr
19.52
Mar2023 ₹43 Cr
46.71
Mar2022 ₹29 Cr
-35.46
Mar2021 ₹45 Cr -

Compare Total Non-Current Liabilities of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹2,163.6 Cr 1% 15.9% 73.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,704.0 Cr 3.5% 5.6% 11.9% Stock Analytics
DIVIS LABORATORIES ₹168,223.0 Cr -1.3% 4.5% 16.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,928.0 Cr -0.7% 6.9% 47.8% Stock Analytics
DR REDDYS LABORATORIES ₹107,368.0 Cr 1.3% 5.1% 17.5% Stock Analytics
CIPLA ₹107,043.0 Cr -1.9% -0.3% -6% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

1%

15.9%

73.9%

SENSEX

-4.6%

-7.5%

6%


You may also like the below Video Courses